AstraZeneca SG&A Expense (Quarterly) Trends

AstraZeneca PLC (AZN)

71.17 +0.33 (+0.47%) USD | NASDAQ | Apr 24, 16:00

72.88 +1.71 (+2.40%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 1995. Upgrade now.

Date	Value
December 31, 2023	3.983B
September 30, 2023	4.929B
June 30, 2023	5.117B
March 31, 2023	4.193B
December 31, 2022	3.806B
September 30, 2022	4.403B
June 30, 2022	4.81B
March 31, 2022	4.965B
December 31, 2021	5.151B
September 30, 2021	4.21B
June 30, 2021	3.201B
March 31, 2021	3.028B
December 31, 2020	3.522B
September 30, 2020	2.829B
June 30, 2020	2.739B
March 31, 2020	2.806B
December 31, 2019	3.082B
September 30, 2019	3.287B
June 30, 2019	3.024B
March 31, 2019	2.592B
December 31, 2018	3.423B
September 30, 2018	2.47B
June 30, 2018	2.635B
March 31, 2018	2.538B
December 31, 2017	3.163B

Date	Value
September 30, 2017	2.573B
June 30, 2017	2.43B
March 31, 2017	2.377B
December 31, 2016	1.469B
September 30, 2016	2.479B
June 30, 2016	3.143B
March 31, 2016	2.648B
December 31, 2015	2.832B
September 30, 2015	2.758B
June 30, 2015	3.05B
March 31, 2015	2.876B
December 31, 2014	4.172B
September 30, 2014	3.219B
June 30, 2014	3.135B
March 31, 2014	2.798B
December 31, 2013	4.714B
September 30, 2013	2.584B
June 30, 2013	2.619B
March 31, 2013	2.595B
December 31, 2012	2.748B
September 30, 2012	2.449B
June 30, 2012	2.425B
March 31, 2012	2.537B
December 31, 2011	3.226B
September 30, 2011	2.737B

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

2.739B

Minimum

Jun 2020

5.151B

Maximum

Dec 2021

3.847B

Average

3.806B

Median

Dec 2022

SG&A Expense (Quarterly) Benchmarks